Cargando…

Population-based study of the durability of humoral immunity after SARS-CoV-2 infection

SARS-CoV-2 antibody quantity and quality are key markers of humoral immunity. However, there is substantial uncertainty about their durability. We investigated levels and temporal change of SARS-CoV-2 antibody quantity and quality. We analyzed sera (8 binding, 4 avidity assays for spike-(S-)protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peterhoff, David, Wiegrebe, Simon, Einhauser, Sebastian, Patt, Arisha J., Beileke, Stephanie, Günther, Felix, Steininger, Philipp, Niller, Hans H., Burkhardt, Ralph, Küchenhoff, Helmut, Gefeller, Olaf, Überla, Klaus, Heid, Iris M., Wagner, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585261/ https://www.ncbi.nlm.nih.gov/pubmed/37868969 http://dx.doi.org/10.3389/fimmu.2023.1242536

Ejemplares similares

Higher Infection Risk among Health Care Workers and Lower Risk among Smokers Persistent across SARS-CoV-2 Waves—Longitudinal Results from the Population-Based TiKoCo Seroprevalence Study
por: Günther, Felix, et al.
Publicado: (2022)

Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation
por: Einhauser, Sebastian, et al.
Publicado: (2021)

Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County—Results from a Population-Based Longitudinal Study in Germany
por: Einhauser, Sebastian, et al.
Publicado: (2022)

Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants
por: Peterhoff, David, et al.
Publicado: (2022)

Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020
por: Wagner, Ralf, et al.
Publicado: (2021)

DNA extraction from clotted blood in genotyping quality
por: Stanzick, Kira J, et al.
Publicado: (2023)

Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination
por: Bauernfeind, Stilla, et al.
Publicado: (2022)

Haplotype Reconstruction Error as a Classical Misclassification Problem: Introducing Sensitivity and Specificity as Error Measures
por: Lamina, Claudia, et al.
Publicado: (2008)

Changes in healthcare seeking and lifestyle in old aged individuals during COVID-19 lockdown in Germany: the population-based AugUR study
por: Brandl, Caroline, et al.
Publicado: (2022)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
por: Bauernfeind, Stilla, et al.
Publicado: (2021)

Retinal Layer Thicknesses in Early Age-Related Macular Degeneration: Results From the German AugUR Study
por: Brandl, Caroline, et al.
Publicado: (2019)

Durability of the humoral immune response in recovered COVID-19 patients
por: Mahallawi, Waleed, et al.
Publicado: (2021)

Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality
por: Hähnel, Viola, et al.
Publicado: (2020)

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
por: Bhattacharya, Deepta
Publicado: (2022)

Analysis of the early COVID-19 epidemic curve in Germany by regression models with change points
por: Küchenhoff, Helmut, et al.
Publicado: (2021)

Humoral immunity for durable control of SARS-CoV-2 and its variants
por: Kotaki, Ryutaro, et al.
Publicado: (2023)

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
por: Vogel, Emanuel, et al.
Publicado: (2022)

Liposome-based high-throughput and point-of-care assays toward the quick, simple, and sensitive detection of neutralizing antibodies against SARS-CoV-2 in patient sera
por: Streif, Simon, et al.
Publicado: (2023)

Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project
por: Zeschick, Nikoletta, et al.
Publicado: (2022)

On the impact of different approaches to classify age-related macular degeneration: Results from the German AugUR study
por: Brandl, Caroline, et al.
Publicado: (2018)

Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
por: Mohn, Kristin G.-I., et al.
Publicado: (2022)

Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions?
por: Klessing, Stephan, et al.
Publicado: (2023)

Cardiovascular Risk Factor Control in 70- to 95-Year-Old Individuals: Cross-Sectional Results from the Population-Based AugUR Study
por: Donhauser, Ferdinand J., et al.
Publicado: (2023)

Children and Ultraviolet Radiation
por: Gefeller, Olaf, et al.
Publicado: (2022)

Nowcasting the COVID‐19 pandemic in Bavaria
por: Günther, Felix, et al.
Publicado: (2020)

Similarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a “Bookmarking” Oncoprotein that Alters the Host Cell Epigenotype?
por: Niller, Hans Helmut, et al.
Publicado: (2012)

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
por: Tenbusch, Matthias, et al.
Publicado: (2021)

Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
por: Laub, Otto, et al.
Publicado: (2021)

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
por: Glück, Vivian, et al.
Publicado: (2022)

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
por: Brockman, Mark A, et al.
Publicado: (2021)

Epidemiological measures for assessing the dynamics of the SARS-CoV-2-outbreak: Simulation study about bias by incomplete case-detection
por: Brinks, Ralph, et al.
Publicado: (2022)

Durability of AZD1222 and hybrid humoral immunity against omicron BA.1 and BA.4
por: Soto-Rifo, Ricardo
Publicado: (2023)

Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals
por: Mader, Anna-Lena, et al.
Publicado: (2022)

Niedrige Inzidenz von SARS-CoV‑2-Infektionen bei Krankenhausmitarbeitern eines Maximalversorgers: Ergebnisse einer prospektiven serologischen Kohortenstudie der ersten und zweiten COVID‑19-Welle
por: Hupf, Julian, et al.
Publicado: (2022)

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
por: Barouch, Dan H., et al.
Publicado: (2021)

Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination
por: Charilaou, Paris, et al.
Publicado: (2022)

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
por: Barouch, Dan H., et al.
Publicado: (2021)

One Year with Methods Open
por: Koch, Sabine, et al.
Publicado: (2017)

May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?
por: Růžek, Daniel, et al.
Publicado: (2013)

Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
por: Warkentin, Lisette, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_icdcikva4ouhr254quqco0tqgf